COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis

14/06/2017 - 14:00

The positive Phase III top-line results indicate that the study successfully met its primary endpoint and BEKINDA ® 24 mg was shown to be effective, safe and well tolerated in patients with acute gastroenteritis and [...]

Novo Nordisk submits application in the EU for including data from the DEVOTE trial in the Tresiba® label

14/06/2017 - 13:03

Bagsværd, Denmark, 14 June 2017 - Novo Nordisk today announced the submission of a Type II Variation application to the European Medicines Agency (EMA) for including data in the label for Tresiba ® (insulin degludec) [...]

Summit Therapeutics plc : 1st Quarter Results

14/06/2017 - 13:00

Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30 APRIL 2017 AND OPERATIONAL PROGRESS Oxford, UK, 14 June 2017 - Summit [...]

Medical Prognosis Institute A/S Announces Start of Subscription Period for Rights Issue

14/06/2017 - 08:12

As of today, Tuesday June 14, 2017, subscription opens for a rights issue in Medical Prognosis Institute A/S (MPI). The rights issue is open to the public. Subscription period ends on Thursday June 29, 2017. A fully [...]

argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML)

14/06/2017 - 08:00

June 14, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

Xbrane Biopharma AB (publ) launch a long-term share savings program for employees

14/06/2017 - 08:00

Press release 2017-06-14 Xbrane Biopharma AB (publ) has launched a long-term share savings program for all employees in both Sweden and Italy. The purpose of the program is to create good conditions for retain and [...]

Enzymatica receives record order from STADA Arzneimittel AG

14/06/2017 - 08:00

Press release Lund, June 14, 2017 Enzymatica has received its largest order to date for a total of about SEK 12 million. The global pharmaceutical company STADA Arzneimittel AG ("STADA"), headquartered in Germany, has [...]

Basilea announces distribution agreement with Avir Pharma Inc. for Cresemba® (isavuconazole) and Zevtera® (ceftobiprole) in Canada

14/06/2017 - 07:15

Basel, Switzerland, June 14, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution and license agreement with Avir Pharma [...]

ABLYNX TO PRESENT ADDITIONAL DATA FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY

14/06/2017 - 07:00

GHENT, Belgium, 14 June 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] announces that it will present additional data from the two Phase IIb studies in rheumatoid arthritis (RA) with its anti-IL-6R Nanobody®, [...]

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

14/06/2017 - 07:00

The board of directors of Targovax ASA (the "Company") has on 14 June 2017, in accordance with the authorisations granted by the general meeting on 5 April 2017, resolved: - to increase the share capital of up to NOK [...]

Orion Corporation: Managers' transactions - Konsta Westerlund

13/06/2017 - 21:15

ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE 2017 at 22.15 EEST Orion Corporation: Managers' transactions - Konsta Westerlund Orion Corporation has received the following disclosure under Market Abuse [...]

Orion Corporation: Managers' transactions - Inka Westerlund

13/06/2017 - 21:10

ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE 2017 at 22.10 EEST Orion Corporation: Managers' transactions - Inka Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation [...]

Orion Corporation: Managers' transactions - Leevi Westerlund

13/06/2017 - 21:00

ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE MONTH 2017 at 22.00 EEST Orion Corporation: Managers' transactions - Leevi Westerlund Orion Corporation has received the following disclosure under Market Abuse [...]

Zinpro Corporation Announces Executive Leadership Changes

13/06/2017 - 18:53

Anderson Promotes Scrimgeour to President & CEO, and Sheffer Joins Company as COO EDEN PRAIRIE, Minn., June 13, 2017 (GLOBE NEWSWIRE) -- Zinpro Corporation announces that its owner, Michael D. Anderson, has promoted [...]

Solon Eiendom ASA - Primary insider notification

13/06/2017 - 16:50

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 13 June 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]

Silmäasema Oyj: Managers' Transactions - Maisa Romanainen

13/06/2017 - 16:00

Silmäasema Oyj - Managers' Transactions Maisa Romanainen 13 June 2017, at 5 p.m. ____________________________________________ Person subject to the notification requirement Name: Romanainen, Maisa Position: Member of [...]

AbCellera Announces Expanded Research Collaboration with Teva

13/06/2017 - 15:00

Collaboration extends initial partnership and aims to generate lead antibody candidates against membrane targets using AbCellera's antibody discovery platform VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE [...]

RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S.

13/06/2017 - 14:00

RedHill has initiated commercial activities in the U.S. with its gastrointestinal-focused sales force, promoting two gastrointestinal specialty products, Donnatal ® and EnteraGam ® TEL-AVIV, Israel and RALEIGH, N.C., [...]

Novo Nordisk A/S - Share repurchase programme

13/06/2017 - 13:21

Bagsværd, Denmark, 13 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]